PHAR fundamentals
An in-depth look to EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) operating, investing, and financing activities
PHAR free cash flow for Q2 24 is -717.61 M EGP. For 2023, PHAR free cash flow was -2.16 B EGP and operating cash flow was 131.84 M EGP.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EGP
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q4 '23
Q1 '24
Q2 '24
TTM